title: Diffuse large B-cell lymphoma with germinal center B-cell phenotype mimicking primary effusion lymphoma.
authors.forename: Yoojoo
authors.initials: Y
authors.lastname: Lim
authors.forename: Tae-Yong
authors.initials: TY
authors.lastname: Kim
authors.forename: In Sil
authors.initials: IS
authors.lastname: Choi
authors.forename: Byung-Su
authors.initials: BS
authors.lastname: Kim
authors.forename: Taek Sang
authors.initials: TS
authors.lastname: Lee
authors.forename: Ji Eun
authors.initials: JE
authors.lastname: Kim
authors.forename: Mee Soo
authors.initials: MS
authors.lastname: Chang
authors.forename: Ki Hwan
authors.initials: KH
authors.lastname: Kim
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D054685:Lymphoma, Primary Effusion / Q000175:diagnosis*; D049268:Positron-Emission Tomography; D011239:Prednisolone / Q000627:therapeutic use; D000069283:Rituximab; D016896:Treatment Outcome; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone